-Lead the life sciences portfolio for a competitive early-stage startup accelerator (1.6k+ applications, 5% acceptance rate).-Advise portfolio companies on strategy, business development and fundraising efforts, securing $35M+ in follow-on investments.-Define and execute sourcing strategy, including supporting research on emerging industry, market and innovation trends.-Conduct comprehensive due diligence on pre-seed to Series A ventures, assessing technical, operational, and commercial viability.-Build, manage and develop a team of 14 subject matter experts (PhDs, Post-Docs, MDs) under a direct-line reporting structure.

-Responsible for corporate strategy and business development for a $1B+ medical products and distribution business.-Led annual strategy and financial planning process, driving full business turnaround and 8% profitable growth (5-Year CAGR).-Facilitated cross-functional review of inorganic opportunities to drive Business Development & Licensing (BD&L) decisions.-Conducted industry, market and competitive analyses to support long-term strategic dialogue and decision-making.-Created presentation materials for Town Hall meetings, Board of Director reviews, earnings calls and investor updates.

-Responsible for driving complex drug development and partnership programs for a rapidly growing, $500M+ oncology company.-Led the Pharmacovigilance Integration Management Office (IMO) for a $2.2B strategic alliance delivering industry best-practices to protect patient safety through M&As and partnerships recognized at the Drug Information Association Conference 2022.-Designed and disseminated long-term corporate strategy deep dive reviews across key functional areas.

-Responsible for structuring, planning and executing global, cross-functional strategic initiatives supporting product and business development, geographic expansion and post M&A integrations for a highly acquisitive, $2B+ medical technology company.-Led a $20M+ surgical reconstruction portfolio delivering 12% organic revenue growth over prior year, 1460% Key Opinion Leader (KOL) base expansion and a behavior-based marketing campaign.-Chief architect of a commercial opportunity assessment process for a $350M orthopedic and regenerative medicine business detailing market sizing, competitive landscapes, customer segmentation and pricing strategies.-Delivered manufacturing plant rationalization strategy considering Design for Six Sigma (DFSS) principles driving $10M+ annualized savings and 50 bps gross margin improvement.-Managed a 100+ person customer experience optimization program delivering $4.5M improved inventory service levels, 12% improved Electronic Data Interchange (EDI) PO conversations and an enterprise-wide competency model.

-Managed cross-functional product and business development teams for a $400M+ biologics and medical device business.-Led due diligence, licensing deal execution, design transfer and commercialization of the Revolve System, an adipose tissue processing platform, generating Year 1 sales 21% above target.-Partnered with executive leadership to develop and kick-off a 5-year, $47M global strategic plan to produce improved scientific, clinical and economic value messaging for pipeline and commercial products.

-Designed and implemented internal quality management strategy and systems in compliance with ISO 13485 and 21 CFR 820.-Documented design control processes in compliance with ISO 9000 and FDA cGMP.-Conducted new market and product opportunity assessments, including construction of supporting business cases addressing detailed technical, regulatory and commercial considerations.-Created marketing collateral and sales training materials for histology and hematology diagnostic devices.

-Designed and executed studies to characterize the clinical performance of orthopedic devices in collaboration with surgeons, clinicians, engineers and upper management.-Performed wear simulator studies on upper extremity and total disc replacement devices in accordance with ASTM and ISO industry standards for regulatory submissions.-Organized, analyzed and interpreted scientific and statistical data for regulatory submissions, expert witness testimonials and peer-reviewed publications.-Trained new employees on general lab practices and internal standard operating procedures for an A2LA (ISO 17025) accredited laboratory.